Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis
scientific article published on 20 December 2019
Author/s
author: Francesca Palandri, Massimo Breccia, Elena Rossi, Giulia Benevolo, Mario Tiribelli, Elisabetta Abruzzese, Roberto Latagliata, Daniela Bartoletti, Florian H Heidel, Massimiliano Bonifacio, Nicola Polverelli, Micaela Bergamaschi, Alessia Tieghi, Monica Crugnola, Francesco Cavazzini, Gianni Binotto, Alessandro Isidori, Nicola Sgherza, Costanza Bosi, Giuseppe Auteri, Luigi Scaffidi, Davide Griguolo, Malgorzata Monika Trawinska, Daniele Cattaneo, Lucia Catani, Mauro Krampera, Roberto M Lemoli, Antonio Cuneo, Gianpietro Semenzato, Francesco Di Raimondo, Michele Cavo
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.